News Features Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions? Todd Neale October 22, 2025
News Features ‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings Michael O'Riordan September 17, 2025
News Features Reimbursement Issues Seem to Be Holding Renal Denervation Back Todd Neale December 19, 2024
News Features Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question L.A. McKeown August 09, 2024
News Features The Promise of Pulsed-Field Ablation: Cautious Optimism Amid Some Unknowns Todd Neale March 29, 2024
News Features FDA Clears AI-ECG Screening Tools for CV Care: What’s Next Is Up for Grabs Yael L. Maxwell December 14, 2023
News Features Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar L.A. McKeown May 12, 2023
News Features Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD? Michael O'Riordan August 15, 2022
News Features TVT 2022 Minorities, Poorer Patients Missing Out on Structural Heart Care Michael O'Riordan June 15, 2022
News Features Reports of Sudden Deaths Among Athletes After COVID-19 Vax Are ‘Misinformation’ Todd Neale February 14, 2022
News Features Realistic Expectations Emerge After Initial Excitement Over Xenotransplant Yael L. Maxwell January 21, 2022
News Features Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path Michael O'Riordan January 17, 2022
News Features Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay? Todd Neale December 09, 2021
News Features Expired Cardiac Devices May Do Global Good, but Safety Unknown Yael L. Maxwell August 26, 2021
News Features Funding the Future: How Industry Support for CV Trials Could Evolve Michael O'Riordan December 17, 2020